Alendronic acid as ionic liquid: New perspective on osteosarcoma

This work was supported by the Associate Laboratory for Green Chemistry LAQV which is financed by national funds from FCT/MCTES (UIDB/50006/2020). The authors also thank Fundacao para a Ciencia e Tecnologia for the projects PTDC/QUI-QOR/32406/2017, PEst-C/LA0006/2013 and RECI/BBBBQB/0230/2012), as w...

ver descrição completa

Detalhes bibliográficos
Autor principal: Teixeira, Sónia (author)
Outros Autores: Santos, Miguel M. (author), Fernandes, Maria H. (author), Costa-Rodrigues, João (author), Branco, Luís C. (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
Active pharmaceutical ingredients
Alendronic acid
Anticancer drugs
API-OSILs
Ionic liquids
Pharmaceutical Science
SDG 3 - Good Health and Well-being
Texto completo:http://hdl.handle.net/10362/98894
País:Portugal
Oai:oai:run.unl.pt:10362/98894

Texto Completo

http://hdl.handle.net/10362/98894

Registos relacionados